Harvard Medical School researchers have uncovered crucial insights into how an emerging class of antiviral drugs works.
Study uncovers key insights about how a new class of antiviral drugs works. Cryo-EM images showed the drugs bound to herpes simplex virus (HSV) protein at nearly atomic detail, while optical tweezers ...
Scientists discover 26 new bacterial species in NASA cleanrooms, revealing surprisingly resilient microbes with potential ...
Discover how a tiny RNA molecule serves as a molecular switch in viral infections, providing insights into phage biology.
AusperBio Completes Patient Enrollment in Phase III AUSHINE Study of AHB-137 for Chronic Hepatitis B
The AUSHINE study is a randomized, double-blind, multicenter Phase III trial evaluating the efficacy and safety of AHB-137 injection in participants with HBeAg-negative CHB treated with nucleos (t)ide ...
Researchers at the Kanazawa University Graduate School of Medical Sciences report in PLOS Pathogens a novel role for the ...
Rare case shows a man living virus free for years after stopping treatment, raising new questions about how the immune system ...
Researchers at the Hebrew University of Jerusalem have identified a conserved small RNA molecule that enables bacteriophages ...
As antibiotic-resistant infections rise and are projected to cause up to 10 million deaths per year by 2050, scientists are looking to bacteriophages, viruses that infect bacteria, as an alternative.
Signal transducer and activator of transcription 3 (STAT3) serves as a critical regulatory molecule in a multitude of physiological processes, encompassing cell proliferation, differentiation, immune ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results